CORINDUS VASCULAR ROBOTICS I's ticker is CVRS and the CUSIP is 218730109. A total of 54 filers reported holding CORINDUS VASCULAR ROBOTICS I in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $2,025,000 | +1050.6% | 473,077 | +699.2% | 0.00% | – |
| Q2 2019 | $176,000 | -34.8% | 59,192 | -61.8% | 0.00% | – |
| Q1 2019 | $270,000 | -16.9% | 155,113 | -59.9% | 0.00% | – |
| Q4 2018 | $325,000 | +128.9% | 386,368 | +124.6% | 0.00% | – |
| Q2 2018 | $142,000 | +389.7% | 171,993 | +710.1% | 0.00% | – |
| Q1 2018 | $29,000 | +81.2% | 21,231 | +31.3% | 0.00% | – |
| Q4 2017 | $16,000 | +300.0% | 16,170 | +584.3% | 0.00% | – |
| Q3 2017 | $4,000 | -76.5% | 2,363 | -75.0% | 0.00% | – |
| Q2 2017 | $17,000 | – | 9,463 | +3243.8% | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 283 | -72.6% | 0.00% | – |
| Q4 2016 | $1,000 | – | 1,033 | +200.3% | 0.00% | – |
| Q3 2016 | $0 | – | 344 | +616.7% | 0.00% | – |
| Q1 2016 | $0 | – | 48 | -59.0% | 0.00% | – |
| Q3 2015 | $0 | -100.0% | 117 | -72.9% | 0.00% | – |
| Q2 2015 | $1,000 | – | 431 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hudson Executive Capital LP | 42,706,635 | $74,310,000 | 2.31% |
| HealthCor Management, L.P. | 19,981,655 | $34,768,000 | 1.40% |
| MASTERS CAPITAL MANAGEMENT LLC | 5,000,000 | $8,700,000 | 0.46% |
| EAM Global Investors LLC | 588,645 | $1,024,000 | 0.45% |
| EAM Investors, LLC | 808,156 | $1,406,000 | 0.34% |
| Schonfeld Strategic Advisors LLC | 1,800,000 | $3,132,000 | 0.11% |
| KENNEDY CAPITAL MANAGEMENT LLC | 1,998,174 | $3,476,000 | 0.04% |
| Canton Hathaway, LLC | 36,750 | $63,000 | 0.04% |
| Tibra Equities Europe Ltd | 209,885 | $365,000 | 0.04% |
| ExodusPoint Capital Management, LP | 210,127 | $366,000 | 0.03% |